{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T03:34:32Z","timestamp":1785382472720,"version":"3.55.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T00:00:00Z","timestamp":1764460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.biopha.2025.118852","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T23:13:33Z","timestamp":1764717213000},"page":"118852","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Harnessing cuproptosis for pancreatic cancer therapy: From molecular insights to clinical prospects"],"prefix":"10.1016","volume":"193","author":[{"given":"Ali","family":"Darzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siavash","family":"Boroumandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pouriya","family":"Khajegi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Dehdashti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedram","family":"Abdali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Moein","family":"Amerinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Kheirkhah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Mahdi","family":"Ajalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahla","family":"Shokouhfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10485","key":"10.1016\/j.biopha.2025.118852_bib1","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0140-6736(25)00261-2","article-title":"Pancreatic cancer","volume":"405","author":"Stoop","year":"2025","journal-title":"Lancet (Lond. Engl. )"},{"issue":"1","key":"10.1016\/j.biopha.2025.118852_bib2","article-title":"Pancreatic cancer: a review of current treatment and novel therapies","volume":"36","author":"Kolbeinsson","year":"2023","journal-title":"J. Invest. Surg. Off. J. Acad. Surg. Res."},{"issue":"5","key":"10.1016\/j.biopha.2025.118852_bib3","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1053\/j.gastro.2023.02.012","article-title":"Pancreatic cancer: changing epidemiology and new approaches to risk assessment, early detection, and prevention","volume":"164","author":"Stoffel","year":"2023","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.biopha.2025.118852_bib4","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","article-title":"Pancreatic cancer: advances and challenges","volume":"186","author":"Halbrook","year":"2023","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.biopha.2025.118852_bib5","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s11605-022-05553-0","article-title":"Pancreatic cancer: genetic conditions and epigenetic alterations","volume":"27","author":"Montalvo-Jav\u00e9","year":"2023","journal-title":"J. Gastrointest. Surg. Off. J. Soc. Surg. Aliment. Trac."},{"key":"10.1016\/j.biopha.2025.118852_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217350","article-title":"Frontiers in pancreatic cancer on biomarkers, microenvironment, and immunotherapy","volume":"610","author":"Yu","year":"2025","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.biopha.2025.118852_bib7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10689-024-00381-4","article-title":"The role of biomarkers in the early detection of pancreatic cancer","volume":"23","author":"Goggins","year":"2024","journal-title":"Fam. Cancer"},{"issue":"5","key":"10.1016\/j.biopha.2025.118852_bib8","doi-asserted-by":"crossref","first-page":"799","DOI":"10.32604\/or.2024.045356","article-title":"Targeting KRAS in pancreatic cancer","volume":"32","author":"Stickler","year":"2024","journal-title":"Oncol. Res."},{"issue":"6","key":"10.1016\/j.biopha.2025.118852_bib9","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.3390\/curroncol31060250","article-title":"Radiochemotherapy in pancreatic cancer","volume":"31","author":"Domaga\u0142a-Haduch","year":"2024","journal-title":"Curr. Oncol. (Tor. Ont. )"},{"issue":"11","key":"10.1016\/j.biopha.2025.118852_bib10","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1093\/carcin\/bgae066","article-title":"Redefining pancreatic cancer management with tumor-agnostic precision medicine","volume":"45","author":"Reddy","year":"2024","journal-title":"Carcinogenesis"},{"issue":"10","key":"10.1016\/j.biopha.2025.118852_bib11","article-title":"Targeting neoadjuvant chemotherapy-induced metabolic reprogramming in pancreatic cancer promotes anti-tumor immunity and chemo-response","volume":"4","author":"Tang","year":"2023","journal-title":"Cell Rep. Med."},{"issue":"2","key":"10.1016\/j.biopha.2025.118852_bib12","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/jjco\/hyy190","article-title":"Randomized phase II\/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02\/JSAP05)","volume":"49","author":"Motoi","year":"2019","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"20","key":"10.1016\/j.biopha.2025.118852_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/cells12202509","article-title":"SLC38A5 modulates ferroptosis to overcome gemcitabine resistance in pancreatic cancer","volume":"12","author":"Kim","year":"2023","journal-title":"Cells"},{"issue":"18","key":"10.1016\/j.biopha.2025.118852_bib14","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2025.118852_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103375","article-title":"A randomized trial of pharmacological ascorbate, gemcitabine, and nab-paclitaxel for metastatic pancreatic cancer","volume":"77","author":"Bodeker","year":"2024","journal-title":"Redox Biol."},{"issue":"75","key":"10.1016\/j.biopha.2025.118852_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abn0704","article-title":"The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer","volume":"7","author":"Mirji","year":"2022","journal-title":"Sci. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118852_bib17","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13045-024-01561-6","article-title":"Current and future immunotherapeutic approaches in pancreatic cancer treatment","volume":"17","author":"Farhangnia","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118852_bib18","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/s41392-022-01229-y","article-title":"Copper homeostasis and cuproptosis in health and disease","volume":"7","author":"Chen","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.biopha.2025.118852_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122223","article-title":"Copper homeostasis and cuproptosis in mitochondria","volume":"334","author":"Tian","year":"2023","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118852_bib20","first-page":"142","article-title":"Ferroptosis inducers enhanced cuproptosis induced by copper ionophores in primary liver cancer","volume":"42","author":"Wang","year":"2023","journal-title":"J. Exp. Clinic. Cancer Res. CR"},{"issue":"1","key":"10.1016\/j.biopha.2025.118852_bib21","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1038\/s41467-023-42025-8","article-title":"Lactylation of METTL16 promotes cuproptosis via m(6)A-modification on FDX1 mRNA in gastric cancer","volume":"14","author":"Sun","year":"2023","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.biopha.2025.118852_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.189013","article-title":"Cuproptosis and cuproptosis-related genes: emerging potential therapeutic targets in breast cancer","volume":"1878","author":"Liu","year":"2023","journal-title":"Biochim. Et. Biophys. Acta Rev. Cancer"},{"issue":"7-8","key":"10.1016\/j.biopha.2025.118852_bib23","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1007\/s10495-023-01845-1","article-title":"FDX1 enhances endometriosis cell cuproptosis via G6PD-mediated redox homeostasis","volume":"28","author":"Lu","year":"2023","journal-title":"Apoptosis Int. J. Programmed Cell Death"},{"issue":"2","key":"10.1016\/j.biopha.2025.118852_bib24","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.3390\/curroncol30020126","article-title":"Expression profiles of cuproptosis-related genes determine distinct subtypes of pancreatic ductal adenocarcinoma","volume":"30","author":"Chen","year":"2023","journal-title":"Curr. Oncol. (Tor. Ont. )"},{"issue":"6","key":"10.1016\/j.biopha.2025.118852_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2024.189180","article-title":"Unveiling cuproptosis: mechanistic insights, roles, and leading advances in oncology","volume":"1879","author":"Zhang","year":"2024","journal-title":"Biochim. Et. Biophys. Acta Rev. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2025.118852_bib26","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13045-022-01392-3","article-title":"Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research","volume":"15","author":"Tong","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"22","key":"10.1016\/j.biopha.2025.118852_bib27","article-title":"Cuproptosis induced by ROS responsive nanoparticles with elesclomol and copper combined with \u03b1PD-L1 for enhanced cancer immunotherapy","volume":"35","author":"Guo","year":"2023","journal-title":"Adv. Mater. (Deerfield Beach Fla)"},{"key":"10.1016\/j.biopha.2025.118852_bib28","article-title":"Crosstalk between ferroptosis and cuproptosis: from mechanism to potential clinical application","volume":"171","author":"Liu","year":"2024","journal-title":"Biomed. Pharmacother. Biomed. Pharmacother."},{"issue":"8","key":"10.1016\/j.biopha.2025.118852_bib29","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.tibs.2024.04.002","article-title":"Protein lipoylation: mitochondria, cuproptosis, and beyond","volume":"49","author":"Lin","year":"2024","journal-title":"Trends Biochem. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118852_bib30","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/imr.13276","article-title":"Copper homeostasis and cuproptosis in cancer immunity and therapy","volume":"321","author":"Liu","year":"2024","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.biopha.2025.118852_bib31","article-title":"Cuproptosis-driven nanostrategies: synergistic nanoplatforms for tumor microenvironment reprogramming and enhanced anticancer efficacy","volume":"32","author":"Cheng","year":"2025","journal-title":"Mater. Today Bio"},{"issue":"1","key":"10.1016\/j.biopha.2025.118852_bib32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12951-025-03186-4","article-title":"Zinc-copper bimetallic nanoplatforms trigger photothermal-amplified cuproptosis and cGAS-STING activation for enhancing triple-negative breast cancer immunotherapy","volume":"23","author":"Zhou","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"18","key":"10.1016\/j.biopha.2025.118852_bib33","article-title":"Elesclomol loaded copper oxide nanoplatform triggers cuproptosis to enhance antitumor immunotherapy","volume":"11","author":"Lu","year":"2024","journal-title":"Adv. Sci. (Weinheim BadenWurttemberg Germany)"},{"issue":"1","key":"10.1016\/j.biopha.2025.118852_bib34","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s10238-024-01491-0","article-title":"lncRNAs as prognostic markers and therapeutic targets in cuproptosis-mediated cancer","volume":"24","author":"Bhat","year":"2024","journal-title":"Clin. Exp. Med."},{"issue":"9","key":"10.1016\/j.biopha.2025.118852_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e19352","article-title":"A cuproptosis-related lncRNA signature for predicting prognosis and immune response in hepatocellular carcinoma","volume":"9","author":"Wu","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.biopha.2025.118852_bib36","article-title":"4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to promote cuproptosis in colorectal cancer","volume":"159","author":"Yang","year":"2023","journal-title":"Biomed. Pharmacother. Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2025.118852_bib37","article-title":"Ferredoxin 1 is a cuproptosis-key gene responsible for tumor immunity and drug sensitivity: a pan-cancer analysis","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118852_bib38","article-title":"Cuproptosis inhibits tumor progression and enhances cisplatin toxicity in ovarian cancer","volume":"39","author":"Zou","year":"2025","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118852_bib39","doi-asserted-by":"crossref","first-page":"333","DOI":"10.32604\/or.2023.028694","article-title":"Drug repositioning of disulfiram induces endometrioid epithelial ovarian cancer cell death via the both apoptosis and cuproptosis pathways","volume":"31","author":"Gan","year":"2023","journal-title":"Oncol. Res."},{"issue":"1","key":"10.1016\/j.biopha.2025.118852_bib40","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s11658-024-00623-4","article-title":"Triptolide-induced cuproptosis is a novel antitumor strategy for the treatment of cervical cancer","volume":"29","author":"Xiao","year":"2024","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.biopha.2025.118852_bib41","article-title":"Baicalein enhances cisplatin sensitivity in cervical cancer cells by promoting cuproptosis through the Akt pathway","volume":"179","author":"Jin","year":"2024","journal-title":"Biomed. Pharmacother. Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.biopha.2025.118852_bib42","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4103\/sjg.sjg_169_24","article-title":"CEBPB dampens the cuproptosis sensitivity of colorectal cancer cells by facilitating the PI3K\/AKT\/mTOR signaling pathway","volume":"30","author":"Huang","year":"2024","journal-title":"Saudi J. Gastroenterol. Off. J. Saudi Gastroenterol. Assoc."},{"issue":"17","key":"10.1016\/j.biopha.2025.118852_bib43","article-title":"AKT1 phosphorylates FDX1 to promote cuproptosis resistance in triple-negative breast cancer","volume":"12","author":"Sun","year":"2025","journal-title":"Adv. Sci. (Weinheim BadenWurttemberg Germany)"},{"issue":"28","key":"10.1016\/j.biopha.2025.118852_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202401646","article-title":"Copper-based composites nanoparticles improve triple-negative breast cancer treatment with induction of apoptosis-cuproptosis and immune activation","volume":"13","author":"Wang","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.biopha.2025.118852_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103302","article-title":"FDX1 downregulation activates mitophagy and the PI3K\/AKT signaling pathway to promote hepatocellular carcinoma progression by inducing ROS production","volume":"75","author":"Sun","year":"2024","journal-title":"Redox Biol."},{"issue":"11","key":"10.1016\/j.biopha.2025.118852_bib46","article-title":"Targeting the TCA cycle through cuproptosis confers synthetic lethality on ARID1A-deficient hepatocellular carcinoma","volume":"4","author":"Xing","year":"2023","journal-title":"Cell Rep. Med."},{"issue":"11","key":"10.1016\/j.biopha.2025.118852_bib47","first-page":"5590","article-title":"LINC02362\/hsa-miR-18a-5p\/FDX1 axis suppresses proliferation and drives cuproptosis and oxaliplatin sensitivity of hepatocellular carcinoma","volume":"13","author":"Quan","year":"2023","journal-title":"Am. J. Cancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2025.118852_bib48","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12935-023-02950-6","article-title":"Targeting copper death genotyping associated gene RARRES2 suppresses glioblastoma progression and macrophages infiltration","volume":"23","author":"Yan","year":"2023","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.biopha.2025.118852_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1220760","article-title":"Development and validation of cuproptosis-related lncRNAs associated with pancreatic cancer immune microenvironment based on single-cell","volume":"14","author":"Sun","year":"2023","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118852_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0323458","article-title":"Comprehensive analysis and experiment validation of five cuproptosis-related genes in prognosis, immune infiltration and metabolic characterization of pancreatic cancer","volume":"20","author":"Deng","year":"2025","journal-title":"PloS One"},{"issue":"Pt A","key":"10.1016\/j.biopha.2025.118852_bib51","article-title":"Prognostic and immune microenvironment analysis of cuproptosis-related lncRNAs in human pancreatic cancer","volume":"197","author":"Duo","year":"2025","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.biopha.2025.118852_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymthe.2025.09.004","article-title":"Elesclomol-copper combination synergistically targets mitochondrial metabolism in cancer stem cells to overcome chemoresistance in PDAC","author":"Yu","year":"2025","journal-title":"Mol. therapy J. Am. Soci. Gene Therapy"},{"issue":"8","key":"10.1016\/j.biopha.2025.118852_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110496","article-title":"Eupalinolide B suppresses pancreatic cancer by ROS generation and potential cuproptosis","volume":"27","author":"Huang","year":"2024","journal-title":"iScience"},{"issue":"13","key":"10.1016\/j.biopha.2025.118852_bib54","article-title":"Stimulus-responsive copper complex nanoparticles induce cuproptosis for augmented cancer immunotherapy","volume":"11","author":"Hu","year":"2024","journal-title":"Adv. Sci. (Weinheim BadenWurttemberg Germany)"},{"issue":"1","key":"10.1016\/j.biopha.2025.118852_bib55","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12935-024-03583-z","article-title":"TWIST1 regulates HK2 ubiquitination degradation to promote pancreatic cancer invasion and metastasis","volume":"25","author":"Wang","year":"2025","journal-title":"Cancer Cell Int."},{"issue":"7","key":"10.1016\/j.biopha.2025.118852_bib56","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1080\/15548627.2023.2165323","article-title":"Copper-dependent autophagic degradation of GPX4 drives ferroptosis","volume":"19","author":"Xue","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.biopha.2025.118852_bib57","article-title":"Cuproptosis-related gene index: a predictor for pancreatic cancer prognosis, immunotherapy efficacy, and chemosensitivity","volume":"13","author":"Huang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2025.118852_bib58","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/4661929","article-title":"Construction of a prognostic model based on cuproptosis-related lncRNA signatures in pancreatic cancer","volume":"2022","author":"Jiang","year":"2022","journal-title":"Can. J. Gastroenterol. Hepatol."},{"issue":"7-8","key":"10.1016\/j.biopha.2025.118852_bib59","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1007\/s10495-023-01843-3","article-title":"Analysis of cuproptosis-related lncRNA signature for predicting prognosis and tumor immune microenvironment in pancreatic cancer","volume":"28","author":"Yao","year":"2023","journal-title":"Apoptosis Int. J. Programmed Cell Death"},{"key":"10.1016\/j.biopha.2025.118852_bib60","article-title":"Cuproptosis-related LncRNAs signature as biomarker of prognosis and immune infiltration in pancreatic cancer","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Genet."},{"issue":"1","key":"10.1016\/j.biopha.2025.118852_bib61","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12885-023-10678-9","article-title":"A novel cuproptosis-related gene model predicts outcomes and treatment responses in pancreatic adenocarcinoma","volume":"23","author":"Liu","year":"2023","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2025.118852_bib62","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2478\/raon-2025-0042","article-title":"Cuproptosis-related gene CEP55 as a biomarker of pancreatic adenocarcinoma via multi-omics techniques and experimental validation","volume":"59","author":"Zhang","year":"2025","journal-title":"Radiol. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118852_bib63","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s10020-025-01180-y","article-title":"Chlorophyllin exerts synergistic anti-tumor effect with gemcitabine in pancreatic cancer by inducing cuproptosis","volume":"31","author":"Ren","year":"2025","journal-title":"Mol. Med. (Camb. Mass)"},{"issue":"1","key":"10.1016\/j.biopha.2025.118852_bib64","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1186\/s12951-024-02968-6","article-title":"A collagenase-decorated Cu-based nanotheranostics: remodeling extracellular matrix for optimizing cuproptosis and MRI in pancreatic ductal adenocarcinoma","volume":"22","author":"Wang","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"42","key":"10.1016\/j.biopha.2025.118852_bib65","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000035167","article-title":"A prognostic and immunotherapy effectiveness model for pancreatic adenocarcinoma based on cuproptosis-related lncRNAs signature","volume":"102","author":"Zhang","year":"2023","journal-title":"Medicine"},{"issue":"4","key":"10.1016\/j.biopha.2025.118852_bib66","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1049\/syb2.12068","article-title":"Cuproptosis-related lncRNAs are correlated with tumour metabolism and immune microenvironment and predict prognosis in pancreatic cancer patients","volume":"17","author":"Wang","year":"2023","journal-title":"IET Syst. Biol."},{"issue":"18","key":"10.1016\/j.biopha.2025.118852_bib67","article-title":"Silk fibroin nanoparticles for enhanced cuproptosis and immunotherapy in pancreatic cancer treatment","volume":"12","author":"Gao","year":"2025","journal-title":"Adv. Sci. (Weinheim BadenWurttemberg Germany)"},{"issue":"30","key":"10.1016\/j.biopha.2025.118852_bib68","article-title":"Sono-triggered cascade lactate depletion by semiconducting polymer nanoreactors for cuproptosis-immunotherapy of pancreatic cancer","volume":"63","author":"Yu","year":"2024","journal-title":"Angew. Chem. (Int. Ed. Engl. )"},{"issue":"1","key":"10.1016\/j.biopha.2025.118852_bib69","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12935-022-02836-z","article-title":"Molecular subtypes based on cuproptosis-related genes and tumor microenvironment infiltration characteristics in pancreatic adenocarcinoma","volume":"23","author":"Li","year":"2023","journal-title":"Cancer Cell Int."},{"issue":"5","key":"10.1016\/j.biopha.2025.118852_bib70","first-page":"2024","article-title":"Identification and validation of a novel cuproptosis signature for stratifying different prognostic, immune, metabolic, and therapeutic landscapes in pancreatic adenocarcinoma","volume":"28","author":"Yan","year":"2024","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2025.118852_bib71","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/3419401","article-title":"A novel cuproptosis-associated gene signature to predict prognosis in patients with pancreatic cancer","volume":"2023","author":"Du","year":"2023","journal-title":"BioMed. Res. Int."},{"issue":"28","key":"10.1016\/j.biopha.2025.118852_bib72","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202301429","article-title":"DNAzyme-mediated cascade nanoreactor for cuproptosis-promoted pancreatic cancer synergistic therapy","volume":"12","author":"Yu","year":"2023","journal-title":"Adv. Healthc. Mater."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225010467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225010467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T06:50:25Z","timestamp":1777013425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225010467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":72,"alternative-id":["S0753332225010467"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118852","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Harnessing cuproptosis for pancreatic cancer therapy: From molecular insights to clinical prospects","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118852","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118852"}}